4-Chloro-3-methoxyaniline

Catalog No.: 
ACBFAH390
CAS No.: 
13726-14-2
Molecular Formula: 
C7H8ClNO
Molecular Weight: 
157.60
4-Chloro-3-methoxyaniline structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100g97%$118.00In stockInquiry
500g97%$571.00In stockInquiry
1000g97%$1008.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name4-Chloro-3-methoxyaniline
IUPAC Name4-chloro-3-methoxyaniline
MDL No.MFCD00672967
Molecular FormulaC7H8ClNO
Molecular Weight157.60
SMILESClC1=C(C=C(N)C=C1)OC
InChI KeyLNKBDFVSILQKSI-UHFFFAOYSA-N
SynonymAM20050226 | DTXSID10518242 | 3-methoxy-4-chloro aniline | 4-chloro-3-methoxybenzenamine;4-Chloro-3-methoxyaniline | cefpodoxime 1-(isopropyloxycarbonyloxy)ethyl ester | 4-chloro-3-(methyloxy)aniline | 4-chloro-3-methoxybenzenamine | 4-chloro-3-methoxy-be
CAS No.13726-14-2
PubChem CID13103692

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302+H312+H332-H315-H319-H335
Precautionary Statement(s)
P261-P280-P305+P351+P338

Synthetic Route by SureRoute

1. ACBFAH390 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACSJIP208 route compound structure diagram
    ACSJIP2081984-58-3In Stock
  2. Plus
  3. ACAYOL972 route compound structure diagram
    ACAYOL97210060-13-6In Stock
  4. Then
  5. ACBFAH390 route product structure diagram
    ACBFAH39013726-14-2In Stock
Inquiry

2. ACBFAH390 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACBFAH390 route product structure diagram
    ACBFAH39013726-14-2In Stock
Inquiry

3. ACBFAH390 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACBFAH390 route product structure diagram
    ACBFAH39013726-14-2In Stock
Inquiry

Comments (0)